Objectives: This study sought to explore the expression patterns of repulsive guidance molecules a (RGMa) in neuromyelitis optica spectrum disorders (NMOSD) and to explore the correlation between RGMa and the clinical features of NMOSD.
Methods: A total of 83 NMOSD patients and 22 age-matched healthy controls (HCs) were enrolled in the study from October 2017 to November 2021. Clinical parameters, including Expanded Disability Status Scale (EDSS) score, degree of MRI enhancement, and AQP4 titer were collected. The expression of serum RGMa was measured by enzyme-linked immunosorbent assay (ELISA) and compared across the four patient groups. The correlation between serum RGMa levels and different clinical parameters was also assessed.
Results: The average serum expression of RGMa in the NMOSD group was significantly higher than that in the HC group ( < 0.001). Among the patient groups, the acute phase group exhibited significantly higher serum RGMa levels than did the remission group (). A multivariate analysis revealed a significant positive correlation between RGMa expression and EDSS score at admission, degree of MRI enhancement, and segmental length of spinal cord lesions. There was a significant negative correlation between the expression of RGMa in NMOSD and the time from attack to sampling or delta EDSS.
Conclusions: The current study suggests that RGMa may be considered a potential biomarker predicting the severity, disability, and clinical features of NMOSD.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850277 | PMC |
| http://dx.doi.org/10.3389/fimmu.2022.766099 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Genetics of constant and severe pain in the NAPS2 cohort of recurrent acute and chronic pancreatitis patients.
J Pain
December 2024
Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA; Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA; Department of Neurobiology, Pittsburgh Center for Pain Research, University of Pittsburgh, Pittsburgh, PA, USA; Department of Cell Biology & Molecular Physiology, University of Pittsburgh, Pittsburgh, PA, USA. Electronic address:
Recurrent acute and chronic pancreatitis (RAP, CP) are complex, progressive inflammatory diseases with variable pain experiences impacting patient function and quality of life. The genetic variants and pain pathways in patients contributing to most severe pain experiences are unknown. We used previously genotyped individuals with RAP/CP from the North American Pancreatitis Study II (NAPS2) of European Ancestry for nested genome-wide associated study (GWAS) for pain-severity, chronicity, or both.
View Article and Find Full Text PDFDevelopment and validation of an ultra-performance liquid chromatography with tandem mass spectrometry method for determination of soluble repulsive guidance molecule A in human serum and cerebrospinal fluid.
Bioanalysis
November 2024
AbbVie Deutschland GmbH & Co. KG, Knollstr., Rhineland-Palatinate, Ludwigshafen, 67061, Germany.
Repulsive guidance molecule A (RGMa) is upregulated in neurodegenerative diseases. To assess RGMa levels in human serum and cerebrospinal fluid (CSF), a quantification method was developed and validated according to ICH M10 guideline. Sample preparation consisted of immunoprecipitation (IP, only for serum), digestion and purification followed by MS.
View Article and Find Full Text PDFIntegrated lipidomic and transcriptomics to explore the effects of ethyl acetate extract of Herpetospermum pedunculosum on nonalcoholic fatty liver disease in mice.
J Ethnopharmacol
January 2025
College of Pharmacy, Southwest Minzu University, Chengdu, 610041, China. Electronic address:
Article Synopsis
- Herpetospermum pedunculosum (HP), a traditional Tibetan herb, has shown potential in modern studies for treating liver damage, specifically in alleviating nonalcoholic fatty liver disease (NAFLD) through its lignan-rich extract (EAHP).
- In an experiment using a mouse model of NAFLD, researchers evaluated EAHP's effects, finding significant improvements in liver health indicators, such as reduced liver size and liver damage markers in the serum, as well as better lipid metabolism.
- Chemical analysis identified 36 compounds in EAHP, and further research indicated it regulates lipid abnormalities and inflammatory responses, showing promise for therapeutic use in liver-related diseases.
Large scale serum proteomics identifies proteins associated with performance decline and clinical milestones in Duchenne muscular dystrophy.
medRxiv
August 2024
Human Genetics Department, Leiden University Medical Center, Leiden, Zuid-Holland, the Netherlands.
Serum biomarkers are promising minimally invasive outcome measures in clinical studies in Duchenne muscular dystrophy (DMD). However, biomarkers strongly associated with clinical progression and predicting performance decline are lacking. In this study we aimed to identify serum biomarkers associated with clinical performance and able to predict clinical milestones in DMD.
View Article and Find Full Text PDFProtein biomarker signature in patients with spinal and bulbar muscular atrophy.
JCI Insight
May 2024
Nido Biosciences, Inc., Boston, Massachusetts, USA.
Article Synopsis
- Spinal and bulbar muscular atrophy (SBMA) is a slowly progressing disease with few sensitive biomarkers for research; this study analyzed patient and control plasma/serum samples to identify potential biomarkers.
- Researchers found 40 proteins significantly associated with SBMA, which were enriched in skeletal muscle and mitochondrial function, and showed better performance than existing clinical tests like creatine kinase in differentiating patients from controls.
- Two specific proteins, EDA2R and RGMA, correlated with poorer survival and body weight in a mouse model, indicating these biomarkers could serve as early predictors of treatment effects in clinical trials.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!